Smoldering Adult T-Cell Leukemia/Lymphoma
1 clinical trials · Condition
◉ Watch Smoldering Adult T-Cell Leukemia/Lymphoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma (NCT02631746) | National Cancer Institute (NCI) | 2017-02-23 |
Track Smoldering Adult T-Cell Leukemia/Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.